Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avid Bioservices Inc

CDMO
Current price
8.62 USD -0.12 USD (-1.37%)
Last closed 8.74 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 554 813 440 USD
Yield for 12 month -42.61 %
1Y
3Y
5Y
10Y
15Y
CDMO
21.11.2021 - 28.11.2021

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Address: 14191 Myford Road, Tustin, CA, United States, 92780

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.5 USD

P/E ratio

Dividend Yield

Current Year

+149 266 000 USD

Last Year

+119 597 000 USD

Current Quarter

+33 815 000 USD

Last Quarter

+25 395 000 USD

Current Year

+31 480 000 USD

Last Year

+36 648 000 USD

Current Quarter

+2 383 000 USD

Last Quarter

-4 665 000 USD

Key Figures CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 318 000 USD
Operating Margin TTM -11.83 %
PE Ratio
Return On Assets TTM -2.27 %
PEG Ratio
Return On Equity TTM -9.67 %
Wall Street Target Price 12.5 USD
Revenue TTM 136 735 008 USD
Book Value 2.84 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -11.1 %
Dividend Yield
Gross Profit TTM 31 480 000 USD
Earnings per share -0.28 USD
Diluted Eps TTM -0.28 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -79.7 %
Profit Margin -12.93 %

Dividend Analytics CDMO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:7
Payout Ratio
Last Split Date 10.07.2017
Dividend Date 10.07.2017

Stock Valuation CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 88.4956
Enterprise Value Revenue 4.1914
Price Sales TTM 3.0243
Enterprise Value EBITDA 978.0362
Price Book MRQ 2.324

Financials CDMO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CDMO

For 52 weeks

4.07 USD 17.39 USD
50 Day MA 7.5 USD
Shares Short Prior Month 11 056 967
200 Day MA 7.69 USD
Short Ratio 10.59
Shares Short 11 862 647
Short Percent 20.78 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics